E-resources
-
Chase, Marianne; Sherman, Alexander V.; Shefner, Jeremy; Chibnik, Lori B.; Vestrucci, Matteo; Cudkowicz, Merit E.; Macklin, Eric; Saville, Ben; Detry, Michelle A.; Chibnik, Lori; Bind, Marie Abele; Paganoni, Sabrina; Nicholson, Katie; Ajroud‐Driss, Senda; Kolb, Stephen; (Simpson) Greene, Ericka; Thonhoff, Jason; Shroff, Sheetal; Goutman, Stephen A.; Feldman, Eva L.; Amber Malcolm, N. P.; Newman, Daniel S.; Owegi, Margaret Ayo; Ghasemi, Mehdi; Fernandes, Joseph Americo M.; Thaisetthawatkul, Pariwat; Rad, Nassim; Ilieva, Hristelina; Judith Guarnieri, N. P.; Jacobsen, Bill; Bowser, Robert; Foster, Laura; Rosenfeld, Jeffrey; Bhuvaneswaran, Karthikeyan; Quinn, Colin; Julia Yasek, N. P.; Fee, Dominic; Deboo, Anahita; Swenson, Andrea; Nance, Christopher; Vu, Tuan; Suresh, Niraja; Caress, Jim; Cartwright, Michael; McIlduff, Courtney; Stommel, Elijah; Glass, Jonathan; Young, Eufrosina; Wymer, James P.; Granit, Volkan; Lewis, Richard; Maragakis, Nicholas J.; Clawson, Lora; Uchil, Alpa; Riley, Kristen; Mosmiller, Betsy; Twydell, Paul; Goyal, Namita A.; Jabari, Duaa; Kasarskis, Edward J.; Shah, Jaimin; Bedlack, Richard; Li, Xiaoyan; Olney, Nicholas; Pattee, Gary L.; Johnson, Kristin; Govindarajan, Raghav; Jones, Vovanti; Chase, Marianne; Sherman, Alex; Eydinov, Matthew; Korin, Alexander; Novak, Ilya; Sinani, Ervin; Katsovskiy, Igor; Whitworth, Isaac; Gladden, Catherine; Tustison, Eric; Jentoft, Katie; Lim, Sangwon; Changkuon, Genevive; Figueroa‐Szostek, Precious; Pothier, Lindsay; DiStefano, Sofia; Kennedy, Erin; Bailey, Abbey; Feulner, Jacob; Gomes, Jassira; DiMarzio, Marisa; Henrique, Jennifer; Grabert, Stacey; Garozzo, Tessa; Randall, Rebecca; Connolly, Mariah; De Santiago, Diana; Lavery, Courtney; Hamilton, Jenny; Small, Catherine; Bulat, Allison; McGarry, Andrew
Annals of neurology, February 2022, 2022-02-00, 20220201, Volume: 91, Issue: 2Journal Article
Current therapeutic development in amyotrophic lateral sclerosis (ALS) relies on individual randomized clinical trials to test a specific investigational product in a single patient population. This approach has intrinsic limitations, including cost, time, and lack of flexibility. Adaptive platform trials represent a novel approach to investigate several interventions for a single disease in a continuous manner. Already in use in oncology, this approach is now being employed more often in neurology. Here, we describe a newly launched platform trial for ALS. The Healey ALS Platform Trial is testing multiple investigational products concurrently in people with ALS, with the goal of rapidly identifying novel treatments, biomarkers, and trial endpoints. ANN NEUROL 2022;91:165–175
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.